Location History:
- San Diego, CA (US) (2006)
- Milpitas, CA (US) (2007 - 2009)
Company Filing History:
1 out of 215 
1 out of 3 
1 out of 62 
Years Active: 2006-2009
Title: The Innovations of Xingjie Chen
Introduction
Xingjie Chen is a notable inventor based in Milpitas, California. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of three patents to his name, Chen's work has the potential to impact various therapeutic applications.
Latest Patents
Among his latest patents is the Anti-CD40 monoclonal antibody, which is designed to act agonistically or antagonistically on CD40. This innovation represents a crucial advancement in the understanding and treatment of diseases that involve the CD40 pathway. The dual functionality of this antibody could lead to new therapeutic strategies in immunology.
Career Highlights
Throughout his career, Xingjie Chen has worked with several prominent companies, including Kirin Beer Kabushiki Kaisha and Gemini Science, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of biotechnology.
Collaborations
Chen has collaborated with esteemed colleagues such as Toshifumi Mikayama and Nobuaki Takahashi. These partnerships have fostered an environment of innovation and have led to the successful development of his patented technologies.
Conclusion
Xingjie Chen's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic applications, particularly in the realm of monoclonal antibodies.